Novel Dry Hyaluronic Acid–Vancomycin Complex Powder for Inhalation, Useful in Pulmonary Infections Associated with Cystic Fibrosis

Impact Factor: 4.9 (2023). 5-Year Impact Factor: 5.5 (2023). Se publicó como preprint en: https://www.preprints.org/manuscript/202402.0587/v1

Guardado en:

Detalles Bibliográficos
Autores principales:	Magi, María S., de Lafuente, Yanina, Quarta, Eride, Palena, María C., Ardiles, Perla del R., Páez, Paulina L., Sonvico, Fabio, Buttini, Francesca, Jimenez Kairuz, Alvaro F.
Otros Autores:	https://orcid.org/0009-0007-8482-4144
Formato:	publishedVersion article
Lenguaje:	Inglés
Publicado:	Academic Editor: Vivek Verma 2024
Materias:	Inhalable vancomycin Cystic fibrosis Polyelectrolyte–drug complex Hyaluronic acid Pulmonary infection
Acceso en línea:	http://hdl.handle.net/11086/552768 https://www.mdpi.com/1999-4923/16/4/436 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11054002/ http://doi.org/10.3390/pharmaceutics16040436
Aporte de:	Repositorio Digital Universitario (UNC) de Universidad Nacional de Córdoba

Ejemplares similares

Cystic fibrosis /
por: Horsley, Alex, et al.
Publicado: (2015)

Cystic fibrosis
Publicado: (2010)

Cystic fibrosis
por: Thomson, Anne H.
Publicado: (2008)

Cystic fibrosis : a guide for patient and family /
por: Orenstein, David M., 1945-
Publicado: (2012)

Genetic diversity of Burkholderia contaminans isolates from cystic fibrosis patients in Argentina
por: Martina, Pablo Francisco, et al.
Publicado: (2013)

Augmented renal clearance in critically ill patients: Incidence, associated factors and effects on vancomycin treatment
por: Campassi, María Luz, et al.
Publicado: (2014)

Pulmonary arterial hypertension /
Publicado: (2012)

Alginate lyase and ciprofloxacin co-immobilization on biopolymeric microspheres for cystic fibrosis treatment
por: Islan, Germán Abel, et al.
Publicado: (2013)

Novel Guanidine Compound against Multidrug-Resistant Cystic Fibrosis-Associated Bacterial Species
por: Saeed, Aamer, et al.
Publicado: (2018)

Consequences of cystic fibrosis transmembrane regulator mutations on inflammatory cells
por: Grumelli, Sandra, et al.
Publicado: (2016)

Validation of a immunoassay for the determination of vancomycin in cerebospinal fluid
por: Marks, Lucrecia, et al.
Publicado: (2019)

High concentrations of sodium chloride improve microbicidal activity of ibuprofen against common cystic fibrosis pathogens
por: Muñoz, Adrián, et al.
Publicado: (2023)

Fourier transform infrared spectroscopy for rapid identification of nonfermenting gram-negative bacteria isolated from sputum samples from cystic fibrosis patients
por: Bosch, María Alejandra, et al.
Publicado: (2008)

Accumulation of hyaluronic acid in rhinoseptoplasty: intraoperative finding
por: Abad-Cuenca, Sebastián, et al.
Publicado: (2025)

Correction to: Low cost and sustainable hyaluronic acid production in a manufacturing platform based on Bacillus subtilis 3NA strain
por: Cerminati, Sebastián, et al.
Publicado: (2022)

The expression of the mitochondrial gene MT-ND4 is downregulated in cystic fibrosis
por: Valdivieso, A.G., et al.

The expression of the mitochondrial gene MT-ND4 is downregulated in cystic fibrosis
por: Valdivieso, Angel Gabriel, et al.
Publicado: (2007)

Low cost and sustainable hyaluronic acid production in a manufacturing platform based on Bacillus subtilis 3NA strain
por: Cerminati, Sebastián, et al.
Publicado: (2022)

First time identification of Pandoraea sputorum from a patient with cystic fibrosis in Argentina : a case report
por: Martina, Pablo Francisco, et al.
Publicado: (2017)

Longitudinal Evolution of the Pseudomonas-Derived Cephalosporinase (PDC) Structure and Activity in a CysticFibrosis Patient Treated with b-Lactams
por: Colque, Claudia A., et al.
Publicado: (2023)

Future advances in pulmonary arterial hypertension
por: Bevacqua, R.J., et al.

Future advances in pulmonary arterial hypertension
Publicado: (2013)

Caracterización de pacientes atendidos en el Hospital de Niños de la Santísima Trinidad, incorporados al Registro Nacional de Fibrosis Quística / RENAFQ. 2012-2018
por: Sansón, SE, et al.
Publicado: (2019)

The Internet Journal of Pulmonary Medicine

Smart lipid nanoparticles containing levofloxacin and DNase for lung delivery: design and characterization
por: Islan, Germán Abel, et al.
Publicado: (2016)

Advances in pulmonary hypertension : edici�on espa�nola.
Publicado: (2014)

Cardiovascular effects of inhaled ultrafine and nanosized particles
Publicado: (2011)

First time identification of <i>Pandoraea sputorum</i> from a patient with cystic fibrosis in Argentina: A case report
por: Martina, Pablo Francisco, et al.
Publicado: (2017)

Splenic cystic lymphangioma
por: Lada, Paúl E., et al.
Publicado: (2010)

Micro/nanostructured hyaluronic acid matrices with tuned swelling and drug release properties
por: Minaberry, Y., et al.

Micro/nanostructured hyaluronic acid matrices with tuned swelling and drug release properties
por: Minaberry, Yanina Susana, et al.
Publicado: (2013)

Interpretation of pulmonary function tests : a practical guide /
por: Hyatt, Robert E., et al.
Publicado: (2014)

Pulmonary embolism following percutaneous vertebroplasty
por: Bedini, Marianela Patricia, et al.
Publicado: (2013)

Effect of wear-corrosion of reduced graphene oxide functionalized with hyaluronic acid on inflammatory and proteomic response of J774A.1 macrophages
por: Sánchez López, Luna, et al.
Publicado: (2023)

Regeneration of the inhalant siphon of Donax hanleyanus (Philippi, 1847) (Bivalvia, donacidae) from Argentina
por: Luzzatto, D.C., et al.

Regeneration of the inhalant siphon of Donax hanleyanus (Philippi, 1847) (Bivalvia, donacidae) from Argentina
Publicado: (2001)

Lung malformation, intralobar pulmonary sequestration
por: Debernardi, Diego M., et al.
Publicado: (2013)

Inhalation toxicology

06 - ANALYSIS OF THE ADHESION ENERGY EXCHANGED IN CD44-HYALURONATE BINDING.
por: D' Arrigo, Mabel
Publicado: (2009)

Polyethylene glycol-phosphatidylethanolamine conjugate as a pulmonary nanocarrier for poorly soluble drug
por: Tan, Yvonne T.F., et al.
Publicado: (2012)